blockchain and digital currency the future of money- Top Block

Ministry of Finance of Korea: Korea's financial market is still facing uncertainty.Oppenheimer: Raise the target price of opening customers from $980 to $1,075, and reiterate the rating of "outperforming the market".US Treasury Department: US Treasury Secretary Yellen expressed appreciation for the close communication between the Ministry of Economic Affairs of Korea and the United States after the recent events in South Korea.

General Motors (GM): The unmanned business Cruise and GM Technical team will be merged, and the plan is expected to be completed in the first half of 2025. According to the priority of GM's capital allocation, GM will no longer fund Cruise's self-driving taxi development business.Policy combination boosts confidence, and public offering: China's assets will usher in a further increase in valuation. On December 9, the Political Bureau of the Communist Party of China (CPC) Central Committee held a meeting to analyze and study the economic work in 2025. A number of public offerings said that the meeting sent a very positive signal. At present, the economy is resilient, the investor structure is constantly optimized, and the market activity continues to increase. China assets may have an opportunity to raise their valuations again. From the perspective of funds, Jing Shun Great Wall Fund analyzed that the current A-share market is in the most active stage since 2015, and there are many potential bulls in the market. Policy expectations are expected to drive incremental funds into the market, forming a resonance between emotions and funds. (SSE)Oppenheimer: Raise the target price of opening customers from $980 to $1,075, and reiterate the rating of "outperforming the market".

Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.The Bank of Korea increased its liquidity to try to calm the market sentiment, and the Bank of Korea increased its capital injection into the financial market, promising to provide "unlimited liquidity" after the political turmoil intensified. According to the website of the Bank of Korea, the liquidity increased by 14.1 trillion won ($9.8 billion) through repurchase operations last week. The scale of such operations was 18.5 trillion won in November and only 1.5 trillion won in October.ZTE signed a strategic cooperation agreement with Daiyu and Midea Group. Recently, ZTE signed a strategic cooperation agreement with Daiyu and Midea Group in Chengdu. In the future, the two sides will carry out in-depth cooperation in VR space, AR application and MR interaction.